PARP inhibitor (class)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PARP inhibitor (class), covering 2024-11-04 to 2024-11-04. Get the full timeline:
Most recent: Clinical Trial Update: PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC [Phase 3]